ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,058Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 229

$594K Total Retail Price of All Prescriptions

Rank: 32 out of 229

738 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 738 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 738 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 737 657 1 1
LISINOPRIL 554 516 2 2
SIMVASTATIN 425 407 3 3
AMLODIPINE BESYLATE 339 314 4 5
OMEPRAZOLE 322 280 5 4
HYDROCODONE-ACETAMINOPHEN 321 272 S3 6 7
ALENDRONATE SODIUM 311 293 7 14
HYDROCHLOROTHIAZIDE 243 204 8 9
LOVASTATIN 240 208 9 11
GABAPENTIN 202 161 10 10
LOSARTAN POTASSIUM 200 195 11 12
METFORMIN HCL 198 183 12 6
METOPROLOL SUCCINATE 190 180 13 16
METOPROLOL TARTRATE 171 163 14 13
ATENOLOL 166 162 15 19
FUROSEMIDE 162 161 16 8
FLUOXETINE HCL 138 129 17 41
ZOLPIDEM TARTRATE 134 118 18 20
TRAMADOL HCL 127 94 19 26
DONEPEZIL HCL 117 117 20 29
ALLOPURINOL 114 110 21 27
CRESTOR 112 108 22 30
SERTRALINE HCL 110 95 23 22
TRAZODONE HCL 101 66 24 34
MIRTAZAPINE 98 98 25 52
JANUVIA 91 88 26 59
GLIMEPIRIDE 88 83 27 63
IBUPROFEN 88 64 27 60
PROAIR HFA 88 59 27 38
ATORVASTATIN CALCIUM 87 81 30 15
CITALOPRAM HBR 84 64 31 21
FELODIPINE ER 83 83 32 61
FLUTICASONE PROPIONATE 82 75 33 23
OXYBUTYNIN CHLORIDE 77 67 34 97
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 52 35 28
FENTANYL 76 75 S2 35 108
MELOXICAM 74 28 37 45
NAMENDA 74 60 37 39
ENDOCET 73 57 S2 39 135
FINASTERIDE 72 72 40 55
RANITIDINE HCL 69 59 41 32
TRIAMCINOLONE ACETONIDE 68 66 42 113
LANTUS 64 50 43 40
AMITRIPTYLINE HCL 63 63 R 44 66
PAROXETINE HCL 62 62 45 49
VENLAFAXINE HCL ER 60 52 46 122
POTASSIUM CHLORIDE 58 58 47 18
INSULIN SYRINGE 57 46 48 83
OXYCONTIN 55 39 S2 49 88
LYRICA 54 44 50 100
ADVAIR DISKUS 53 50 51 47
ZETIA 52 52 52 93
PANTOPRAZOLE SODIUM 52 44 52 33
DOXAZOSIN MESYLATE 52 52 52 50
DICLOFENAC SODIUM 50 39 55 168
LOSARTAN-HYDROCHLOROTHIAZIDE 50 48 55 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.